These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1380533)

  • 1. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells.
    Norton SD; Zuckerman L; Urdahl KB; Shefner R; Miller J; Jenkins MK
    J Immunol; 1992 Sep; 149(5):1556-61. PubMed ID: 1380533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
    Jenkins MK; Taylor PS; Norton SD; Urdahl KB
    J Immunol; 1991 Oct; 147(8):2461-6. PubMed ID: 1717561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
    Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
    J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting cell-depleted human T lymphocytes.
    Ohnishi H; Tanaka T; Takahara J; Kotb M
    J Immunol; 1993 Apr; 150(8 Pt 1):3207-14. PubMed ID: 7682235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
    Van Gool SW; de Boer M; Ceuppens JL
    J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRC OX-2 defines a novel T cell costimulatory pathway.
    Borriello F; Lederer J; Scott S; Sharpe AH
    J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement of class I major histocompatibility complex molecules by cell surface CD8 delivers an activation signal.
    Geppert TD; Nguyen H; Lipsky PE
    Eur J Immunol; 1992 Jun; 22(6):1379-83. PubMed ID: 1350981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.
    Galvin F; Freeman GJ; Razi-Wolf Z; Hall W; Benacerraf B; Nadler L; Reiser H
    J Immunol; 1992 Dec; 149(12):3802-8. PubMed ID: 1281187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C; Croft M; Swain SL
    J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7.
    Damle NK; Linsley PS; Ledbetter JA
    Eur J Immunol; 1991 May; 21(5):1277-82. PubMed ID: 1645270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
    Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
    J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.
    Nabavi N; Freeman GJ; Gault A; Godfrey D; Nadler LM; Glimcher LH
    Nature; 1992 Nov; 360(6401):266-8. PubMed ID: 1279442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.
    Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
    J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.
    Sansom DM; Hall ND
    Eur J Immunol; 1993 Jan; 23(1):295-8. PubMed ID: 7678229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.